ACTIVE

REYNDERS PHARMACEUTICAL LABELS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result9,2 M €-7,7 %over 1 year

Revenue42,4 M €+0,3 %over 1 year

Equity15,1 M €+26,8 %over 1 year

Workforce130,0 ETP+6,7 %over 1 year

Identity

Source · BCE/KBO

REYNDERS PHARMACEUTICAL LABELS is a Public limited company incorporated in 1991. Its main activity is: Manufacture of articles of paper and paperboard. Its registered office is in Boechout. It employs on average 130,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0443.025.922
Incorporation: 15/01/1991
Legal form: Public limited company
Registered office: Nijverheidsstraat 15
2530 Boechout · FlandreSee on map
Contributed capital: 375 000,00 €
Latest accounts: 31/12/2025
Average workforce: 130,0 ETP

Activities (NACE)

17250Manufacture of articles of paper and paperboard· main 17290Manufacture of other articles of paper and paperboard 18120Other printing 18120Other printing 21250Manufacture of pharmaceutical preparations 22220Manufacture of plastic packing goods

Joint committees (5)

130
1300
200
2000
218

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 18 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	42,4 M €	+0.3%	42,2 M €	+7.7%	39,2 M €	+6.5%	36,8 M €	+20.9%	30,5 M €
EBITDA	13,3 M €	-5.6%	14,1 M €	+8.8%	12,9 M €	+2.3%	12,6 M €	+29.9%	9,7 M €
Operating result	12 M €	-7.6%	13 M €	+3.0%	12,7 M €	+17.4%	10,8 M €	+23.2%	8,8 M €
Net result	9,2 M €	-7.7%	10 M €	+2.3%	9,7 M €	+14.9%	8,5 M €	+25.2%	6,8 M €
Balance sheet
Equity	15,1 M €	+26.8%	11,9 M €	+40.5%	8,5 M €	-60.4%	21,4 M €	+31.8%	16,2 M €
Total assets	28,4 M €	+0.2%	28,3 M €	+12.5%	25,2 M €	-1.8%	25,6 M €	+27.7%	20,1 M €
Cash	11,1 M €	+4.4%	10,6 M €	+27.3%	8,3 M €	-11.1%	9,4 M €	+32.1%	7,1 M €
Debts	12,5 M €	-20.4%	15,7 M €	-0.7%	15,8 M €	+364%	3,4 M €	+1.4%	3,4 M €
Other
Workforce	130,0 ETP	+6.7%	121,8 ETP	+3.0%	118,2 ETP	+4.1%	113,5 ETP	+6.1%	107,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
LINTACKER CONSULTING0861.171.245Represented by Jacques Reynders	Director01/11/2003 → 15/05/2026
REYNESCO INVEST0554.769.625Represented by Marc Reynders	Managing director25/06/2014 → 15/05/2026Director15/05/2014 → 2020 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
MRS CONSULTING0861.171.146Represented by Sebastiaan Reynders	Director10/07/2020 → 2020 accounts
VELDKANT0435.084.689Represented by Paul Reynders	Director10/07/2020 → 2020 accountsManaging director10/07/2020 → 19/04/2023

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	19/05/2026	23/04/2025	22/04/2024	05/07/2023	15/06/2022	14/06/2021
General meeting	20/04/2026	22/04/2025	22/04/2024	20/05/2023	20/05/2022	15/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	20/04/2026	19/05/2026	Dutch	PDF
Full model	31/12/2024	22/04/2025	23/04/2025	Dutch	PDF
Full model	31/12/2023	22/04/2024	22/04/2024	Dutch	PDF
Full model	31/12/2022	20/05/2023	05/07/2023	Dutch	PDF
Full model	31/12/2021	20/05/2022	15/06/2022	Dutch	PDF
Full model	31/12/2020	15/05/2021	14/06/2021	Dutch	PDF
Full model	31/12/2019	01/06/2020	30/06/2020	Dutch	PDF
Full model	31/12/2018	15/05/2019	14/06/2019	Dutch	PDF
Full model	31/12/2017	15/05/2018	25/06/2018	Dutch	PDF
Full model	31/12/2016	15/05/2017	14/06/2017	Dutch	PDF
Full model	31/12/2015	16/05/2016	02/06/2016	Dutch	PDF
Full model	31/12/2014	15/05/2015	19/05/2015	Dutch	PDF
Full model	31/12/2013	15/05/2014	20/05/2014	Dutch	PDF
Full model	31/12/2012	15/05/2013	23/05/2013	Dutch	PDF
Full model	31/12/2011	15/05/2012	05/06/2012	Dutch	PDF
Full model	31/12/2010	15/05/2011	31/05/2011	Dutch	PDF
Full model	31/12/2009	15/05/2010	19/05/2010	Dutch	PDF
Full model	31/12/2008	15/05/2009	09/06/2009	Dutch	PDF
Full model	31/12/2007	15/05/2008	09/06/2008	Dutch	PDF
Full model	31/12/2006	15/05/2007	15/05/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
LINTACKER CONSULTING0861.171.245Represented by Jacques Reynders	Director01/11/2003 → 15/05/2026
REYNESCO INVEST0554.769.625Represented by Marc Reynders	Managing director25/06/2014 → 15/05/2026Director15/05/2014 → 2020 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
MRS CONSULTING0861.171.146Represented by Sebastiaan Reynders	Director10/07/2020 → 2020 accounts
VELDKANT0435.084.689Represented by Paul Reynders	Director10/07/2020 → 2020 accountsManaging director10/07/2020 → 19/04/2023

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates11/06/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Other04/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - DOEL - ALGEMENE VERGADERING
PDF
Mandates19/09/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/10/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/07/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/02/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates01/07/2019
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings18 filings

Mandates

REYNESCO INVEST

LINTACKER CONSULTING

VELDKANT

MRS CONSULTING

REYNESCO

PRS Consult BVBA

Paul Reynders

Marc Reynders

Jacques Reynders

199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

REYNDERS PHARMACEUTICAL LABELS

Nijverheidsstraat 15, 2530 Boechout

Managing directorDirector

Director

DirectorManaging director

Director

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Nijverheidsstraat 15, 2530 BoechoutCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00117908

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
REYNDERS PHARMACEUTICAL LABELSCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00117908

Events

2025
Annual accounts 20259,2 M €↓
2024
Annual accounts 202410 M €↑
2023
Annual accounts 20239,7 M €↑
2022
Annual accounts 20228,5 M €↑
2021
Annual accounts 20216,8 M €↑
2018
Annual accounts 20184,2 M €↑
2017
Annual accounts 20174 M €↑
2016
Annual accounts 20163,4 M €↑
2015
Annual accounts 20153,4 M €↑
2014
Annual accounts 20143 M €↑
2013
Annual accounts 20132,8 M €↑
2012
Annual accounts 20122,3 M €↑
2011
Annual accounts 20111,8 M €↑
2010
Annual accounts 20101,6 M €↑
2009
Annual accounts 20091,1 M €↑
2008
Annual accounts 2008978,4 k €↓
2007
Annual accounts 20071,3 M €↓
2006
Annual accounts 20061,3 M €
15/01/1991
IncorporationPublic limited company

REYNDERS PHARMACEUTICAL LABELS

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events